Andere talen Neumora Therapeutics, Inc.

Aandelen

NMRA

US6409791000

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 10-05-2024			Nabeurs 01:32:10
9,19 ^USD	-5,94%		9,17	-0,22%

07/05	Aandelen Neumora Therapeutics dalen na kleiner verlies in Q1	MT
07/05	Neumora Therapeutics, Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Neumora Therapeutics Shares Fall as Q1 Loss Narrows	07/05
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	07/05
Neumora Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
Neumora Therapeutics to Participate in Upcoming Conferences in May	06/05
Sector Update: Health Care Stocks Advance Premarket Monday	15/04
Sector Update: Health Care	15/04
Investors Shrug Off Geopolitical Concerns, Driving Premarket Gains for US Equity Futures	15/04
Upcoming Earnings Buoy Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday	15/04
Top Premarket Decliners	15/04
Neumora Therapeutics' Phase 1 Trial of Potential Brain Disease Drug on Hold After Convulsions in Rabbits	15/04
Neumora Shares Slide Premarket as FDA Puts Early Study of Schizophrenia Drug on Hold	15/04
Neumora's early-stage schizophrenia drug study put on hold	15/04
U.S. FDA places clinical hold on Neumora's schizophrenia drug study	15/04
Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study	15/04
Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study	15/04
Neumora Therapeutics, Inc.(NasdaqGS:NMRA) added to S&P Global BMI Index	18/03
Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days	13/03
Certain Common Stock of Neumora Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 12-MAR-2024.	12/03
Certain Stock Options of Neumora Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 12-MAR-2024.	12/03
Neumora Therapeutics Q4 Loss Narrows	07/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Neumora Therapeutics, Inc.

Aandelen

NMRA

US6409791000

Andere talen

Filters